Navidea Biopharmaceuticals Incの時価総額
Navidea Biopharmaceuticals Incの時価総額は何ですか。
Navidea Biopharmaceuticals Incの時価総額は9.71M$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
NYSEMKTのセクタHealth Careにおける時価総額の企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似の時価総額
- Botswana Diamonds plcの時価総額は9.69M$です。
- Softimat S.Aの時価総額は9.69M$です。
- China Automotive Interior Decorationの時価総額は9.69M$です。
- Zhuoxin Internationalの時価総額は9.69M$です。
- Lamtexの時価総額は9.70M$です。
- Chakana Copperの時価総額は9.70M$です。
- Navidea Biopharmaceuticals Incの時価総額は9.71M$です。
- Pittards plcの時価総額は9.71M$です。
- Surge Explorationの時価総額は9.71M$です。
- Deson Development Internationalの時価総額は9.72M$です。
- Golden Arrow Resourcesの時価総額は9.72M$です。
- Lee Hing Developmentの時価総額は9.72M$です。
- Guardion Health Sciences Incの時価総額は9.73M$です。